Bio-Rad Advances InteliQ Quality Controls Product Line
Optimized open vial stability will now enable any instrument platform to utilize the full range of InteliQ products.
Optimized open vial stability will now enable any instrument platform to utilize the full range of InteliQ products.
The sets are for monitoring serological assays for analytes such as HIV 1 and 2, hepatitis B and C viruses, syphilis, and HTLV types I and II.
: Enhancing Zeiss Celldiscoverer 7 with Zeiss LSM 900 enables users to perform superresolution 3-D imaging with up to 1.5x higher resolution.
Innovative products featured by exhibitors at the American Association for Clinical Chemistry 2019 scientific meeting and clinical lab expo.
Read MoreThe ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test cleared for the US market.
Read MoreOn a variety of lab and POC platforms, HbA1c testing is playing an increasingly important role.
Read MoreThe laser features dual photomultiplier tube detection and a 337 nm laser for exceptional processing speed and maximum sensitivity.
Read MoreThe Binding Site provides ethically sourced serum and plasma biological materials from a variety of disease-state conditions in human organs and tissues.
Read MoreLot-to-lot reagent inconsistencies can have significant effects on patient test results.
Read MoreThe rule applies to devices marketed after May 28, 1976, when the medical device amendments to the Federal Food, Drug, and Cosmetic Act were signed into law.
Read MoreMiddleware and Cloud-based systems drive efficiency in the clinical laboratory.
Read MoreJanuary 2019’s tech guide features lab and point-of-care glucose monitoring systems from companies Akray, Nova Biomedical, Dexcom, and Oak Tree Medical.
Read MoreBiometric screening gives early health warnings, improves productivity, and boosts morale.
Read MoreA powerful combination of automated urine microscopy and digital imaging produces greater accuracy while reducing manual intervention time.
Read MoreHologic’s first-in-category assay, cleared through FDA’s De Novo review process, provides laboratories with a highly sensitive and specific molecular diagnostic method to identify M. genitalium infections and enable effective treatment.
Read MoreThe MenoCheck assay was developed to aid physicians in determining the status of women during menopausal transition.
Read MoreThe molecular test is the first of its type approved to report genotypes as final results.
Read MoreIn a recent study, the company’s IMMray biomarker signatures achieved accuracy greater than 90% when diagnosing CCP-negative rheumatoid arthritis patients compared to healthy controls.
Read More